Abstract
Neurolymphomatosis is a rare manifestation of non-Hodgkin's lymphoma (NHL) and is
characterized by infiltration of the nerves by neoplastic lymphoid cells and is seen
in up to 0.2% of all NHL cases. Diagnosing this syndrome is quite a challenge to the
hematologists given the vague symptoms and signs and the low incidence. Newer imaging
modalities such as positron emission tomography–computed tomography and magnetic resonance
imaging have enabled early diagnosis with a sensitivity reaching up to 100%. Despite
a variety of therapies reported in the literature for the treatment, the prognosis
is very poor. We report a 46-year-old male diagnosed to have NHL–diffuse large B-cell
lymphoma and treated with rituximab, cyclophosphamide, vincristine, and prednisolone
(R-CHOP) therapy who presented with left brachial plexus neurolymphomatosis as the
initial feature of disease relapse.
Keywords
Brachial plexus - chemotherapy - neurolymphomatosis - non-Hodgkin's lymphoma